Attention Investors: Don’t Miss Out on This Trillion-Dollar Trend

This trend could be the biggest opportunity of our investing lives.

| More on:
The Motley Fool

There is a coming trend that will make a whole bunch of investors rich. In fact, I’ve seen estimates that say this opportunity will be worth more than $1 trillion, and that’s just in Canada. Investors who capitalize on this trend for all of North America stand to benefit even more.

If it’s a trillion-dollar trend, I must be talking about something truly groundbreaking. Is it driverless cars? A new type of microchip that we can implant directly into our brains? A way to get unlimited energy without harming the environment? A new type of delicious cookie that actually burns calories?

Well, not exactly. In fact, this idea is actually pretty mundane. But that doesn’t make it any less important, nor does it take anything away from the opportunity awaiting investors.

I’m talking about keeping baby boomers healthy throughout their retirement. In Canada alone, more than 9.6 million people born between 1946 and 1964 will be retiring in the next 15 years, and most will end up living many more productive years. This is a good thing for everyone, especially companies that specialize in caring for seniors.

Here are four Canadian companies that are going to benefit as the population gets older.

Chartwell 

Chartwell Retirement Residences (TSX: CSH.UN) is Canada’s largest owner and operator of seniors assisted living facilities, with 181 properties stretched across the country. The company also owns 39 residences in the United States.

Right now, Chartwell is in acquisition mode, preparing for the onslaught of demand that is coming. Since the industry is somewhat fragmented across the country, there are all sorts of facilities that the company can snap up. And as demand increases, so will prices charged to seniors who need the facilities. This should, in turn, lead to increased profits and an increase to the company’s 5.1% yield.

Extendicare

Chartwell’s main competitor in Canada is Extendicare (TSX: EXE), which operates 88 facilities here. It also runs 158 in the U.S., and has a division that provides home care to seniors who aren’t quite ready to live in an assisted living facility.

Chartwell has had a terrific dividend history, not missing a payment since it went public in 2004. Extendicare can’t make the same claim, as it cut its dividend twice — once in 2009, and again in 2013. While investors never want to see a dividend cut, recent results had the company earning 77 cents per share from operations, easily enough to cover the 48 cents per share dividend.

Investors looking for a little extra yield should choose Extendicare, which pays out a 6.7% dividend.

Valeant Pharmaceuticals

While Chartwell and Extendicare take care of more basic needs, Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX) is focused on things like tropical creams for skin conditions and eye health solutions. It has many products that are designed to make skin look younger, something that is important to many baby boomers.

The company is also in the middle of a hostile bid for Allergan. It’s a natural fit, since Allergan is in many of the same niche markets. Some of its main products include Botox wrinkle treatment, various kinds of eye drops, and breast implants.

These are hardly the types of pharmaceuticals that are important to someone’s health, but they will sell to baby boomers who are desperate for ways to avoid being reminded about how old they are.

Alimentation Couche-Tard

One thing I realized when I watched my grandparents grow old is how difficult it was for them to move around. Even mundane tasks like cutting the grass or going to the grocery store became a challenge.

My grandmother went a step further, choosing to shop at the local Alimentation Couche-Tard (TSX: ATD.B) store for her staples. Sure, the price of milk and bread were higher, but she gladly made that trade-off so she could shop closer to home and not have to walk around a huge grocery store.

As Couche-Tard continues its ambitious growth plans, it’s setting itself up perfectly to cater to older shoppers. Stores are small, carry most of the staples, and are usually located in urban locations. Any additional stores are likely to be purchased in the U.S., or Europe, where there are lots of older people who don’t move around so well any more. Mostly by accident, the company has successfully made its stores appealing to retirees.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith does not own shares of any company mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Happy family father of mother and child daughter launch a kite on nature at sunset
Investing

3 Soaring Stocks to Hold for the Next 20 Years

These three stocks are good bets for the long haul, given their healthy long-term growth prospects.

Read more »

grow dividends
Tech Stocks

Celestica Stock Is up 44% Since Earnings: What Investors Need to Know

Celestica continues to benefit from strong demand and production efficiencies, yet the stock remains undervalued.

Read more »

A plant grows from coins.
Investing

2 Dividend Stocks Paying 5% or More That Could Beat the Market in 2024 and Beyond 

Here are two top dividend stocks long-term investors may certainly want to consider for their yields and growth profiles right…

Read more »

edit Balloon shaped as a heart
Dividend Stocks

Love Value Stocks? 2 That Are Screaming Buys in May 2024

Patience can pay off by investing in these two value stocks with nice dividends and the potential to turn around.

Read more »

healthcare pharma
Tech Stocks

What’s Going on With WELL Health Stock?

WELL stock (TSX:WELL) made strong moves once again, with record earnings and even higher guidance for 2024.

Read more »

Senior Couple Walking With Pet Bulldog In Countryside
Dividend Stocks

2 Everlasting Canadian Stocks for Your RRSP

The Canadian National Railway (TSX:CNR) stock is worth owning for the long haul.

Read more »

money cash dividends
Stocks for Beginners

Is TD Stock the Best Dividend Stock for You?

Shares of TD stock (TSX:TD) plunged on the news of a money laundering probe. But could this mean it's a…

Read more »

exchange traded funds
Investing

New to Investing? Get Started With This Easy, Hands-Off Method

Vanguard S&P 500 Index ETF (CAD-hedged) (TSX:VSP) is a glorious first investment candidate for beginner investors.

Read more »